Mr. Erik van den Berg

CEO

Over 25 years’ industry experience and proven track record in leading and growing companies
Successfully completed over 20 transactions and partnerships, including a $600 million alliance with Pfizer, $290 million partnership with Kyowa Kirin and $500M in equity and debt financings for biotechnology companies from seed through IPO
Former CEO of AM-Pharma where he remains on its Board
Chairman of Step Pharma, TargED Therapeutics, co-founder and previous (executive) Chairman of Lava Therapeutics and co-founder and previous (executive) Chairman of Heatmatrix Group (sold to BosNieuwkerk)
Master’s degree in chemistry and MBA